NEW YORK (GenomeWeb News) — Bio-Rad Laboratories and Beckman Coulter have extended by eight years an alliance to develop and manufacture immunodiagnostic products that test for viral and infectious disease, Bio-Rad said today.
Under the new agreement, Bio-Rad said it will develop new blood-based immunoassays, including tests for hepatitis B and HIV, for Beckman’s UniCel and Access systems.
The company said some of these assays will test for chronic hepatitis or active infection, and that it plans to develop a next-generation HIV assay to detect the virus.
Financial terms of the extended agreement were not disclosed.